View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Modality Solutions
15 June 2016

Modality Solutions’ Partner Bioconvergence® Rebrands as Singota™ Solutions

Life-sciences contract service provider BioConvergence has rebranded as Singota Solutions to respond to its client’s needs.

As part of the transition, the company expanded its services in line of CEO Alisa Wright’s strategic plan. She said: "We continually seek new ways to improve patients’ lives by helping our clients accelerate their product development process. This has been our mission from the start of the company ten years ago. This project, like our past expansions, fills a critical need expressed by our clients."

The expansion will require construction of clean rooms and installation of equipment necessary to fill injectable drug products into vials, syringes, and cartridges for clients in the pharmaceutical industry. This added capability complements the company’s existing services, which span from formulation development to finished product for use in clinical trials.

Senior Director of Operations Brent Lieffers said, "This expansion not only brings innovative technology to our clients, but also creates new employment opportunities in our community."

Concurrent with the expansion, the company name will transition to Singota™ Solutions. This reflects its continued growth as a contract development and manufacturing organisation (CDMO) and its commitment to accelerating the drug development process through innovative solutions.

President of the Bloomington Economic Development Corporation Lynn Coyne commented: "This major expansion of an already successful life-science company signals a very bright future for BioConvergence. Its creativity and innovation make it a market leader and we are grateful that the company has chosen to stay and grow in Monroe County."

Wright added: "On behalf of everyone at the company, we are excited about the future and we deeply appreciate the support from the local community."

The company will make further progress announcements over the coming months.

BioConvergence is a contract service provider to the life sciences industry, which offers outsourcing partnerships for formulation development, testing, labelling, and kitting, as well as supply chain services. Headquartered in Bloomington in Indiana, BioConvergence has over 50 employees with many years of valuable experience in the pharmaceutical and biotechnology industries. The unique E-Transparency® System provides flexibility to clients while offering superior, quality-driven outsourcing services.

Competing priorities, changing expectations, cost pressures, sustainability initiatives, emerging markets - these are some of the challenges facing cold chain management professionals every day. Solutions...
Regenerative medicine is a novel biomolecular approach to exciting new clinical therapies. Generally, this grouping involves three major therapy applications: cell therapies or stem cell...
Immunomedics ( is a clinical-stage biopharmaceutical company developing monoclonal antibody-based products for the targeted treatment of cancer.
Bristol-Myers Squibb (BMS) is a global biopharmaceutical company headquartered in New York City that specialises in discovering, developing and delivering innovative medicines for patients with...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology